AMD - Age-Related Macular Degeneration

Ophthalmology
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

NV
Notal VisionVA - Manassas
1 program
Notal Vision Optical Coherence Tomography Device Version 2.5N/A1 trial
Active Trials
NCT03969303CompletedEst. Oct 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Notal VisionNotal Vision Optical Coherence Tomography Device Version 2.5

Clinical Trials (1)

NCT03969303Notal VisionNotal Vision Optical Coherence Tomography Device Version 2.5

NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients

Start: Oct 2018Est. completion: Oct 2019
N/ACompleted

Related Jobs in Ophthalmology

Lead Data Manager

Genomics
Remote
11h ago

Cleanroom and Laboratory Technician

SAB BIO
11h ago

Material Handler - 8 Hour Day Shift

Pfizer
United States - Kansas - McPherson
Yesterday

Senior Process Technician - Rotating 2nd Shift

Pfizer
United States - Massachusetts - Andover
Yesterday
$27 - $45/hr

Staff Equipment and Systems Engineer

Johnson & Johnson
Plymouth, Minnesota, United States of America
Yesterday
$94K - $152K/yr

APAC Regulatory Affairs Manager

Johnson & Johnson
Singapore, Singapore
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Myopia(127)Cataract(116)Open-Angle Glaucoma(102)Glaucoma(92)Dry Eye(74)Age-Related Macular Degeneration(73)Dry Eye Disease(43)Neovascular Age-related Macular Degeneration(40)Macular Degeneration(37)Diabetic Retinopathy(25)